🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-10
Trial ID
NCT00008151
This is a prospective, single-center phase 1 clinical study aimed at determ...
Status
Completed
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2019-05-24
Trial ID
NCT03848754
This study will test an experimental combination of the drugs Mylotarg and ...
Status
Completed
Location
UCSD Moores Cancer Center
Start Date
2005-07
Trial ID
NCT00766116
Treatments Being Tested
Randomized Phase-III, two-arm, open-label, multi-center study in adult pati...
Status
Completed
Location
Medizinische Universitäts Graz
Start Date
2010-05-12
Trial ID
NCT00893399
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Unknown
Location
Ziekenhuis Netwerk Antwerpen Middelheim
Start Date
2004-06
Trial ID
NCT00091234
Treatments Being Tested
The trial is open to all patients with a diagnosis of acute promyelocytic l...
Status
Recruiting
Location
Hôpital Universitaire des Enfants Reine Fabiola (Huderf)
Start Date
2019-10-09
Trial ID
NCT04793919
Treatments Being Tested
This phase I trial studies the best dose and side effects of liposomal cyta...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-05-21
Trial ID
NCT04915612
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03390296
The main objective of this study is to compare conventional chemotherapy: d...
Status
Completed
Location
CH
Start Date
2007-12
Trial ID
NCT00927498
This is a single-arm, open-label, Phase 4 study evaluating the effect of GO...
Status
Completed
Location
Augusta University Medical Center Clinical Research Pharmacy
Start Date
2019-07-03
Trial ID
NCT03727750
Treatments Being Tested